This document discusses recombinant DNA vaccines. It begins with an introduction to vaccines and their role in preventing disease through immunization. It then explains recombinant DNA technology and how it is used to develop recombinant vaccines. There are three main types of recombinant vaccines: live genetically modified organisms, recombinant inactivated vaccines which are subunit vaccines, and genetic vaccines like DNA vaccines. The document outlines the advantages of recombinant vaccines as being safer, more efficacious, less expensive and faster to produce. It also notes some potential limitations like insufficient technology and lack of complete disease knowledge. In the conclusion, it briefly discusses the most advanced COVID-19 vaccine candidates currently in clinical development.